Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals significant growth in pharmacist participation in Medicaid, indicating potential for expanded services.
Introduction States increasingly recognize pharmacists as medical-benefit providers, yet participation under Medicaid is not well documented. Methods We conducted a retrospective descriptive analysis of pharmacist-submitted claims to the Ohio Department of Medicaid from January 2017 to January 2025. Claims included CPT/ICD-10 codes, paid/denied status, payment amounts, and place of service. Results Pharmacists submitted 1,424 claims before implementation and nearly 250,000 afterward, with more than 85% paid and $4.4 million reimbursed. Most claims occurred in team-based settings (federally qualified health centers (55%) and office practices (41%)) while community-pharmacy billing was rare (0.19%). Common services included E/M visits, preventive counseling, and continuous glucose monitoring; leading diagnoses were type 2 diabetes, hypertension, and nicotine dependence. Conclusion Recognition of pharmacists as medical-benefit providers produced rapid participation at modest cost, primarily in integrated clinical settings. These findings suggest that streamlined referral processes and improved billing support may expand participation, particularly in community pharmacies.
No takes yet. Share an insight, caveat, or question.
Murphy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: